Authors
Smyth, EKouvelakis, K
Cunningham, D
Hahne, JC
Peckitt, C
Vlachogiannis, G
Watkins, D
Rao, S
Starling, N
Wilson, SH
Waddell, Thomas
Okines, A
Crosby, T
Mansoor, Was
Wadsley, J
Middleton, G
Wotherspoon, A
Chau, I
Valeri, N
Affiliation
Gastrointestinal Oncology, Royal Marsden Hospital NHS Foundation Trust, London, UKIssue Date
2018
Metadata
Show full item recordCitation
Smyth E, Kouvelakis K, Cunningham D, Hahne JC, Peckitt C, Vlachogiannis G, et al. 646P EGFR amplification (amp) and survival in the REAL-3 trial. Annals of Oncology. 2018;29(suppl_8).Journal
Annals of OncologyDOI
10.1093/annonc/mdy282.030PubMed ID
No PMIDAdditional Links
https://dx.doi.org/10.1093/annonc/mdy282.030Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy282.030